Auxly Cannabis Group Inc.

TSX:XLY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.53 +0.00%

+$0.00 today

Market cap
$364.42M
Beta
1.16
P/E (TTM)
7.3
EPS (TTM)
$0.02
52W Low $0.08High $0.19

Volume 0.13M

Average 0.71M

XLY.TO Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Auxly Cannabis Group Inc.TSX: XLY.TO

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses turns positive

Q1 FY2026 other income / expenses was CA$8.53M, compared with -CA$2.22M a year earlier. Trailing-twelve-month other income / expenses was CA$10.6M.

Context

  • Other income / expenses amounted to 0.1% of revenue in FY2025, down 12.2 pp from a year earlier.
  • Other income / expenses grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other income / expenses holds near CA$8.53M or moves back toward the trailing-twelve-month quarterly average of CA$2.65M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$8.53M+661.7% QoQ
Last fiscal yearDec 2025
-CA$155K+99.0% YoY
LTMMar 2026
CA$10.6M+210.4% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+483.4%——
1 year+99.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

CAD · from the income statement

Latest · FY2025
(155K) CAD
Year-over-year change
+99.0%

Other Income / Expenses vs competitors

How XLY.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +210.4% is the highest of 4, against a peer median of +11.8%.
  • Other income / expenses amounts to 6.7% of revenue for XLY.TO, versus a peer median of 6.9%.
XLY.TO Competitors
Other Income / Expenses for XLY.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$10.6M CAD+210.4%—6.7%
CRDL.TOCardiol Therapeutics Inc.LTM Mar 2026-CA$755.78K CAD-116.7%-63.7%—
HLS.TOHLS Therapeutics Inc.LTM Mar 2026-$6.61M USD+11.8%—11.9%
CRRX.TOCareRx CorporationLTM Mar 2026-CA$7.23M CAD+14.9%—1.9%
Peer median (excluding XLY.TO) —+11.8%-63.7%6.9%

Competitors are the stored peer set for XLY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue83.83M94.47M101.08M122.33M151.48M
Cost of Revenue64.54M77.96M79.8M62.4M64.74M
Gross Profit19.29M16.51M21.28M59.93M86.74M
Gross Margin23.0%17.5%21.1%49.0%57.3%
Research & Development298K292K497K00
Selling, General & Admin45.42M50.38M40.28M40.73M49.07M
Operating Expenses58.23M65.49M47.23M45.22M54.07M
Depreciation & Amortization14.27M20.18M11.21M10.28M11.45M
EBITDA(18.3M)(94.79M)(10.89M)24.38M50.31M
EBITDA Margin-21.8%-100.3%-10.8%19.9%33.2%
Operating Income(38.94M)(48.98M)(25.95M)14.71M32.67M
Operating Margin-46.4%-51.8%-25.7%12.0%21.6%
Interest Income1.59M337K32K240K130K
Interest Expense17.67M21.58M25.65M14.46M6.34M
Other Income / Expenses(11.3M)(87.58M)(21.8M)(15.07M)(155K)
Income Before Tax(50.24M)(136.56M)(47.75M)(356K)32.52M
Pre-Tax Margin-59.9%-144.5%-47.2%-0.3%21.5%
Income Tax Expense(4.33M)(6.26M)(3.24M)15.99M(9.34M)
Net Income(33.74M)(130.29M)(44.51M)(16.35M)41.86M
Net Margin-40.2%-137.9%-44.0%-13.4%27.6%
EPS (Basic)(0.06)(0.15)(0.04)(0.01)0.03
EPS (Diluted)(0.06)(0.15)(0.04)(0.01)0.03
Weighted Avg Shares783.38M889.87M990.99M1.2B1.33B
Weighted Avg Shares (Diluted)783.38M889.87M990.99M1.2B1.59B

Auxly Cannabis Group Inc.

TSX:XLY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.